Search Results

You searched for : umifenovir  

	No significant clinical benefit with Umifenovir addition in COVID-19 treatment: Glenmark clinical study Umifenovir did not show superior clinical outcomes when added to Favipiravir treatment. The trial did not meet key end-points ... Oct 21
	Glenmark introduces higher strength 400 mg FabiFlu tablets for COVID-19 treatment Glenmark the first company to launch Favipiravir in India now launches 400 mg tablets... Aug 06
	Glenmark commences 1000 patients surveillance study ; FabiFlu Glenmark has also completed the phase 3 clinical trial with Favipiravir (FabiFlu) in mild to moderate COVID-19 patients in India... Jul 13
	CSIR and Laxai Sciences partners for COVID clinical trials CSIR and Laxai Sciences to seek regulatory approval for clinical trials on COVID-19 patients using combinations of antiviral and host-directed therapies... Jul 08
	Glenmark receive approval for oral antiviral Favipiravir ; COVID-19 treatment Glenmark is the first pharmaceutical company in India to receive approval for antiviral Favipiravir for mild to moderate covid patients... Jun 20
	Umifenovir gets DCGI nod for Phase III clinical trial against COVID-19 Phase 3 Trials will be carried out at King George’s Medical University, Dr Ram Manohar Lohia Institute and Lucknow Medical College... Jun 19
	Glenmark starts Phase 3 trials on Antiviral drug Favipiravir for treatment of COVID-19 patients in India Glenmark is the first company in India to initiate Phase 3 clinical trials on Favipiravir for COVID-19 patients in India... May 26
	Glenmark Pharmaceuticals to start combined antiviral test for Covid-19 cure Glenmark to commence phase 3 clinical trial to test combined efficacy Favipiravir and Umifenovir ... May 26
8 Matching result(s) found!

Trending Now
	Clinical Interventions in Chronic Hepatitis B and C: Antiviral Efficacy, Liver Fibrosis Scoring, and Monitoring August 11, 2026
	Common Health Mistakes Indians Should Avoid: A Practical Guide to Everyday WellnessAugust 11, 2026
	How to Build a Healthy Lifestyle After 40: A Practical Guide for Indian AdultsAugust 11, 2026
	Milk Microbiome Could Hold New Clues to Lifelong Health, Experts SayAugust 10, 2026
	Globally Renowned Dermatologist and Sesderma Founder Professor Dr. Gabriel Serrano to Visit India to Showcase Cutting-Edge Derma-Tech for Indian Skincare at Scientific Symposiums Hosted by Iberia PharmaceuticalsAugust 10, 2026
	Sharda Hospital Celebrates World Breastfeeding Week with a Week-Long Awareness ProgrammeAugust 10, 2026
	Swinburne University of Technology Opens Applications for Master of Engineering ScienceAugust 10, 2026
	GLP-1 Receptor Agonists: A New Era in Weight Loss TreatmentAugust 10, 2026
	Immunotherapy vs. Chemotherapy: Understanding the Mechanisms of Precision OncologyAugust 10, 2026
	Mitigating Tech-Induced Ailments: Managing Screen Time, Sedentary Lifestyles, and Dry Eye SyndromeAugust 10, 2026
	The Blueprint of Validation: Navigating Medical AI’s "Reckoning Year"August 10, 2026
	The Future of Smart Hospitals: Redefining Healthcare Delivery in India August 10, 2026
	Healthcare Data Security in India: Risks, Threats, and Best Practices for a Digital-First Health EcosystemAugust 10, 2026
	The Science of Resilience: Psychological Strategies for Modern StressAugust 08, 2026
	The Science of Fasting: 2026 Research on Autophagy and LongevityAugust 08, 2026
	Early Markers of Insulin Resistance: Moving Beyond Fasting Blood SugarAugust 08, 2026
	Healthcare Management Challenges in India: What Hospital Leaders Must Address NowAugust 08, 2026
	Importance of Patient Safety: Why Every Hospital in India Must Prioritize ItAugust 08, 2026
	Decoding Fatty Liver Disease: Symptoms, Reversibility, and the MASLD/NAFLD SpectrumAugust 07, 2026
	Heart-Healthy Dietary Patterns: Translating Clinical Nutrition Guidelines into Daily MealsAugust 07, 2026